Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
Due to limited systemic treatment options, peritoneal carcinomatosis of gastric origin is still associated with a dismal outcome and is claimed a terminal disease. In the past, surgery had not been considered as a potential treatment option. However, there is emerging evidence that in selected patie...
Enregistré dans:
| Auteurs principaux: | Thomas Boerner, Pompiliu Piso |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ecb0e7185dfe447bb874fced6406f369 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Implementation of the enhanced
recovery after surgery protocol for patients with peritoneal
carcinomatosis undergoing cytoreductive surgery and
hyperthermic intraperitoneal chemoperfusion
par: Oleksandr Ivanovych Tkachenko, et autres
Publié: (2021) -
The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications
par: Siyuan Qian, et autres
Publié: (2021) -
Carcinomatosis peritoneal secundaria a carcinoma mucoepidermoide de glándula salival
par: Sánchez P.,Marcelo, et autres
Publié: (2018) -
Imaging of Gastric Carcinomatosis
par: Raquel Saiz Martínez, et autres
Publié: (2021) -
CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review
par: Panagiota Berta Panagiotopoulou, et autres
Publié: (2021)